• Explore /
  • Poster
  • / Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).

Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).

Abstract Poster

Authors

null

Charlotte Stahlfeld

Department of Medicine, University of Wisconsin-Madison, Madison, WI

Charlotte Stahlfeld , Hamid Emamekhoo , Katherine Kaufmann , Petros Grivas , Moshe Chaim Ornstein , Iris Yeong- Fung Sheng , Caroline Burkey , Jamie Sperger , Rory M. Bade , Jennifer L. Schehr , Amy K Taylor , Yue Shi , Shuang Zhao , Joshua Michael Lang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 547)

DOI

10.1200/JCO.2023.41.6_suppl.547

Abstract #

547

Poster Bd #

M10

Abstract Disclosures

Similar Posters

First Author: Mathilde Cancel

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Circulating tumor cells (CTCs) as liquid biopsies in patients with metastatic colorectal cancer versus other GI malignancies.

Circulating tumor cells (CTCs) as liquid biopsies in patients with metastatic colorectal cancer versus other GI malignancies.

First Author: Pashtoon Murtaza Kasi

First Author: Katherine L. Pogue-Geile

First Author: Jean-Yves Pierga